A Novel Role for the Bcl-2 Protein Family: Specific Suppression of the RAD51 Recombination Pathway

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2001 May 15

PMID 11350949

Citations 26

Authors

Y Saintigny

A Dumay

S Lambert

B S Lopez

Affiliations

Soon will be listed here.

Abstract

The oncogenic role of Bcl-2 is generally attributed to its protective effect against apoptosis. Here, we show a novel role for Bcl-2: the specific inhibition of the conservative RAD51 recombination pathway. Bcl-2 or Bcl-X(L) overexpression inhibits UV-C-, gamma-ray- or mutant p53-induced homologous recombination (HR). Moreover, Bcl-2 recombination inhibition is independent of the role of p53 in G1 arrest. At an acute double-strand break in the recombination substrate, Bcl-2 specifically inhibits RAD51-dependent gene conversion without affecting non-conservative recombination. Bcl-2 consistently thwarts recombination stimulated by RAD51 overexpression and alters Rad51 protein by post-translation modification. Moreover, a mutant (G145A)Bcl-2, which is defective in Bax interaction and in apoptosis repression, also inhibits recombination, showing that the death and recombination repression functions of Bcl-2 are separable. Inhibition of error-free repair pathways by Bcl-2 results in elevated frequencies of mutagenesis. The Bcl-2 gene therefore combines two separable cancer-prone phenotypes: apoptosis repression and a genetic instability/mutator phenotype. This dual phenotype could represent a mammalian version of the bacterial SOS repair system.

Citing Articles

An Adverse Outcome Pathway Network for Chemically Induced Oxidative Stress Leading to (Non)genotoxic Carcinogenesis.

Veltman C, Pennings J, van de Water B, Luijten M Chem Res Toxicol. 2023; 36(6):805-817.

PMID: 37156502 PMC: 10283045. DOI: 10.1021/acs.chemrestox.2c00396.

Homologous recombination, cancer and the 'RAD51 paradox'.

Matos-Rodrigues G, Guirouilh-Barbat J, Martini E, Lopez B NAR Cancer. 2021; 3(2):zcab016.

PMID: 34316706 PMC: 8209977. DOI: 10.1093/narcan/zcab016.

Nutraceutical Compounds as Sensitizers for Cancer Treatment in Radiation Therapy.

Calvaruso M, Pucci G, Musso R, Bravata V, Cammarata F, Russo G Int J Mol Sci. 2019; 20(21).

PMID: 31652849 PMC: 6861933. DOI: 10.3390/ijms20215267.

Serum Levels of Inflammatory Cytokines and Expression of BCL2 and BAX mRNA in Peripheral Blood Mononuclear Cells and in Patients with Chronic Heart Failure.

Liu W, Ru L, Su C, Qi S, Qi X Med Sci Monit. 2019; 25:2633-2639.

PMID: 30968846 PMC: 6474297. DOI: 10.12659/MSM.912457.

Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.

Rivera-Torres N, Banas K, Bialk P, Bloh K, Kmiec E PLoS One. 2017; 12(1):e0169350.

PMID: 28052104 PMC: 5214427. DOI: 10.1371/journal.pone.0169350.

References

Huang D, OReilly L, Strasser A, Cory S . The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 1997; 16(15):4628-38. PMC: 1170089. DOI: 10.1093/emboj/16.15.4628. View

Rich T, Watson C, Wyllie A . Apoptosis: the germs of death. Nat Cell Biol. 1999; 1(3):E69-71. DOI: 10.1038/11038. View

LEA D, COULSON C . The distribution of the numbers of mutants in bacterial populations. J Genet. 2014; 49(3):264-85. DOI: 10.1007/BF02986080. View

Levine A, Momand J, Finlay C . The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-6. DOI: 10.1038/351453a0. View

Kuo M, Shiah S, Wang C, Chuang S . Suppression of apoptosis by Bcl-2 to enhance benzene metabolites-induced oxidative DNA damage and mutagenesis: A possible mechanism of carcinogenesis. Mol Pharmacol. 1999; 55(5):894-901. View

Chen G, Yuan S, Liu W, Xu Y, Trujillo K, Song B . Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem. 1999; 274(18):12748-52. DOI: 10.1074/jbc.274.18.12748. View

OConnor L, Strasser A, OReilly L, Hausmann G, Adams J, Cory S . Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 1998; 17(2):384-95. PMC: 1170389. DOI: 10.1093/emboj/17.2.384. View

Liu Y, Naumovski L, Hanawalt P . Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that overexpress BCL2. Cancer Res. 1997; 57(9):1650-3. View

Lambert S, Lopez B . Characterization of mammalian RAD51 double strand break repair using non-lethal dominant-negative forms. EMBO J. 2000; 19(12):3090-9. PMC: 203369. DOI: 10.1093/emboj/19.12.3090. View

10.

Liang F, Han M, Romanienko P, Jasin M . Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc Natl Acad Sci U S A. 1998; 95(9):5172-7. PMC: 20233. DOI: 10.1073/pnas.95.9.5172. View

11.

Haaf T, Golub E, Reddy G, Radding C, Ward D . Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci U S A. 1995; 92(6):2298-302. PMC: 42471. DOI: 10.1073/pnas.92.6.2298. View

12.

Yuan Z, Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kharbanda S . Regulation of Rad51 function by c-Abl in response to DNA damage. J Biol Chem. 1998; 273(7):3799-802. DOI: 10.1074/jbc.273.7.3799. View

13.

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

14.

Wyllie A, Bellamy C, Bubb V, Clarke A, Corbet S, Curtis L . Apoptosis and carcinogenesis. Br J Cancer. 1999; 80 Suppl 1:34-7. View

15.

Cleary M, Sklar J . Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985; 82(21):7439-43. PMC: 391360. DOI: 10.1073/pnas.82.21.7439. View

16.

Strasser A, Harris A, Jacks T, Cory S . DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 1994; 79(2):329-39. DOI: 10.1016/0092-8674(94)90201-1. View

17.

CAPIZZI R, JAMESON J . A table for the estimation of the spontaneous mutation rate of cells in culture. Mutat Res. 1973; 17(1):147-8. DOI: 10.1016/0027-5107(73)90265-0. View

18.

Flygare J, Armstrong R, Wennborg A, Orsan S, Hellgren D . Proteolytic cleavage of HsRad51 during apoptosis. FEBS Lett. 1998; 427(2):247-51. DOI: 10.1016/s0014-5793(98)00433-5. View

19.

Smith M, Fornace Jr A . Genomic instability and the role of p53 mutations in cancer cells. Curr Opin Oncol. 1995; 7(1):69-75. View

20.

Hu T, Miller C, Ridder G, Aardema M . Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res. 1999; 426(1):51-62. DOI: 10.1016/s0027-5107(99)00077-9. View